Details of the Drug-Related molecule(s) Interaction Atlas

General Information of DTT (ID: TTG043C)

DTT Name	Tumor necrosis factor receptor type I (TNF-R1) DTT Info
Gene Name	TNFRSF1A

Molecule-Related Drug & Molecule List

Molecule-Related Drug List

Molecule Type:

DTT

DTP

DME

Drug Status:

Clinical Trial Drug(s)

Discontinued Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

4 Clinical Trial Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
VB-111	DMX04CA	Malignant glioma	2A00.0	Phase 3	[1]
Drug 2862277	DM8WU3O	Acute lung injury	NB32.3	Phase 2	[2]
AVX-470	DMAKD0I	Inflammatory bowel disease	DD72	Phase 1	[3]
GSK1995057	DMC14KV	Adult respiratory distress syndrome	CB00	Phase 1	[4]
------------------------------------------------------------------------------------

1 Discontinued Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Anti-IFN gamma	DMXI185	Alopecia	ED70	Terminated	[3]
------------------------------------------------------------------------------------

9 Investigative Drug(s) Transported by This DTP

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ADS-0101	DMP7IS0	Chronic obstructive pulmonary disease	CA22	Investigative	[2]
ALF-421	DM53KRA	Acute liver failure	DB91	Investigative	[3]
Anti-TNF human mabs	DMYKTF6	Autoimmune diabetes	5A10	Investigative	[3]
NM-2014	DM6RA20	Rheumatoid arthritis	FA20	Investigative	[2]
NM-9405	DMKMBSJ	Rheumatoid arthritis	FA20	Investigative	[2]
Recombinant human TNF receptor	DMLYQWV	Arthritis	FA20	Investigative	[3]
TNFcept	DMAGI7K	Rheumatoid arthritis	FA20	Investigative	[3]
TNFmab	DM4T0ZF	Rheumatoid arthritis	FA20	Investigative	[3]
TNFR1 NAM	DMPTQEG	Multiple sclerosis	8A40	Investigative	[2]
------------------------------------------------------------------------------------


⏷ Show the Full List of 9 Investigative Drug(s)

Molecule Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

References

1	Phase I dose-escalation study of VB-111, an antiangiogenic virotherapy, in patients with advanced solid tumors.Clin Cancer Res.2013 Jul 15;19(14):3996-4007.
2	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1870).
3	Secretion of a TNFR:Fc fusion protein following pulmonary administration of pseudotyped adeno-associated virus vectors. J Virol. 2004 Nov;78(22):12355-65.
4	Autoantibodies to variable heavy (VH) chain Ig sequences in humans impact the safety and clinical pharmacology of a VH domain antibody antagonist of TNF-alpha receptor 1. J Clin Immunol. 2013 Oct;33(7):1192-203.